Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT00949897
Other study ID # 120813B
Secondary ID
Status Withdrawn
Phase Phase 4
First received July 29, 2009
Last updated March 11, 2013
Start date March 2009
Est. completion date June 2011

Study information

Verified date March 2013
Source OrthoCarolina Research Institute, Inc.
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

The purpose of this study is to compare the clinical and radiographic outcomes of a randomized, consecutive series of adult patients, with an acquired flatfoot, treated with a lateral column lengthening using an allograft bone wedge versus a titanium porous metal implant (Biofoam, Wright Medical).

Null hypothesis: At six months postoperatively, there is no difference in the degree of correction as measured by the talonavicular coverage angle between patients randomized to allograft and Biofoam.

Alternative hypothesis: At six months postoperatively, the degree of correction as measured by the talonavicular coverage angle will be less in patients randomized to allograft than the degree of correction in patients randomized to Biofoam.


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date June 2011
Est. primary completion date June 2011
Accepts healthy volunteers No
Gender Both
Age group 25 Years to 75 Years
Eligibility Inclusion Criteria:

- Ages 25-75

- Unresponsive to conservative treatment

- Patient with acquired flatfoot deformity, who is a candidate for lateral column lengthening (Stage IIB) = (greater than > 40% uncoverage of talar head by navicular on standing AP radiograph)

Exclusion Criteria:

- Less than 25 years of age and greater than 75 years

- Pre-existing infection

- Peripheral neuropathy

- Charcot arthropathy

- Peripheral vascular disease

- Rhematoid Arthritis (RA) or inflammatory arthropathy

- Metal allergy or sensitivity to metal

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Device:
Biofoam
Device
Other:
Iliac Crest Allograft with locked plate


Locations

Country Name City State
United States OrthoCarolina, P.A. Charlotte North Carolina

Sponsors (2)

Lead Sponsor Collaborator
OrthoCarolina Research Institute, Inc. Wright Medical Technology

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary The degree of correction as measured by talonavicular coverage angle, which is used to quantify the degree of deformity. Degree of correction is defined as the difference between the preoperative and postoperative talonavicular coverage angle. 2 weeks, 6 weeks, 12 weeks, and 6 months No
Secondary American Orthopaedic Foot and Ankle Society (AOFAS) Ankle-Hindfoot Score 2 weeks, 6 weeks, 3 months, and 6 months No
Secondary Foot Function Index (FFI) Score 2 weeks, 6 weeks, 3 months, and 6 months No
Secondary Pain Visual Analog Scale (VAS) 2 weeks, 6 weeks, 3 months, and 6 months No
Secondary Implant failure 2 weeks, 6 weeks, 3 months, and 6 months No